| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 07/31/1997 | WO1997027319A1 Compositions and methods for determining anti-viral drug susceptibility and resistance and anti-viral drug screening |
| 07/31/1997 | WO1997027310A1 Retroviral vector and its use in gene therapy |
| 07/31/1997 | WO1997027308A1 Plant tissue/stage specific promoters for regulated expression of transgenes in plants |
| 07/31/1997 | WO1997027307A1 Raspberry promoters for expression of transgenes in plants |
| 07/31/1997 | WO1997027304A1 Para-nitrobenzyl esterases with enhanced activity in aqueous and nonaqueous media |
| 07/31/1997 | WO1997027299A1 Mammalian cx3c chemokine genes |
| 07/31/1997 | WO1997027296A1 Nucleic acids and proteins related to alzheimer's disease, and uses therefor |
| 07/31/1997 | WO1997027288A1 New attenuated strain of the virus causing the porcine reproductive respiratory syndrome (prrs), vaccines and diagnostic means obtainable with said strain, and production process |
| 07/31/1997 | WO1997027286A1 Methods for using the obese gene and its gene product to stimulate hematopoietic development |
| 07/31/1997 | WO1997027285A1 Cloned plant p-hydroxyphenyl pyruvic acid dioxygenase |
| 07/31/1997 | WO1997027213A1 Methods for screening for transdominant effector peptides and rna molecules |
| 07/31/1997 | WO1997027212A1 Methods for screening for transdominant intracellular effector peptides and rna molecules |
| 07/31/1997 | WO1997027208A1 Unique associated kaposi's sarcoma virus sequences and uses thereof |
| 07/31/1997 | WO1997027207A1 A plant nuclear scaffold attachment region which increases gene expression |
| 07/31/1997 | WO1997026918A2 Ligand directed enzyme prodrug therapy |
| 07/31/1997 | WO1997026902A1 Cells for treating dementia |
| 07/31/1997 | WO1997026901A1 Regeneration of nerves in the central nervous system |
| 07/31/1997 | WO1997026862A2 Improved concentrated injection and infusion solutions for intravenous administration |
| 07/31/1997 | WO1997026853A2 Dna encoding galanin galr2 receptors and uses thereof |
| 07/31/1997 | DE19545351C1 Eukaryotische Zellen mit Hybridrezeptor und dadurch steuerbarem Genkonstrukt, Verfahren zu deren Herstellung und Verwendung dieser Zellen in der Gentherapie Eukaryotic cells with hybrid receptor and thereby controllable gene construct, to processes for their preparation and use of these cells for gene therapy |
| 07/31/1997 | CA2244900A1 Regeneration of nerves in the central nervous system |
| 07/31/1997 | CA2244693A1 Methods for using the obese gene and its gene product to stimulate hematopoietic development |
| 07/31/1997 | CA2244373A1 Unique associated kaposi's sarcoma virus sequences and uses thereof |
| 07/31/1997 | CA2244222A1 Methods for screening for transdominant effector peptides and rna molecules |
| 07/31/1997 | CA2243969A1 Plant tissue/stage specific promoters for regulated expression of transgenes in plants |
| 07/31/1997 | CA2243850A1 Raspberry promoters for expression of transgenes in plants |
| 07/31/1997 | CA2243529A1 Retroviral vector and its use in gene therapy |
| 07/31/1997 | CA2216436A1 New attenuated strain of the virus causing the porcine reproductive and respiratory syndrome (prrs), vaccines and diagnostic kits derived from the same, and procedures for the obtaining of the same |
| 07/31/1997 | CA2216227A1 Dna encoding galanin galr2 receptors and uses thereof |
| 07/30/1997 | EP0786522A2 Enzymatic RNA molecules for treatment of stenotic conditions |
| 07/30/1997 | EP0786519A2 Staphylococcus aureus polynucleotides and sequences |
| 07/30/1997 | EP0786474A1 A recombinant buman factor VIII derivative |
| 07/30/1997 | EP0786088A2 Presentation of hydrophobic antigens to t-cells by cd1 molecules |
| 07/30/1997 | EP0786084A1 Method for screening compositions |
| 07/30/1997 | EP0786007A1 Transgenic nonhuman animal having functionally disrupted interleukin-1-beta converting enzyme gene |
| 07/30/1997 | EP0786004A1 Cloning, expression and characterisation of a novel form of phosphatidylinositol-3-kinase |
| 07/30/1997 | EP0786002A1 Intracellular isoform of the interleukin-1 receptor antagonist |
| 07/30/1997 | EP0785999A1 Plant transcription regulators from circovirus |
| 07/30/1997 | EP0785992A1 Conditional transformation of genetically engineered cells |
| 07/30/1997 | EP0785990A1 Method for stimulating profileration of colon cells using pomc 76-103 |
| 07/30/1997 | EP0785950A2 Keratinocyte growth factor analogs |
| 07/30/1997 | EP0785948A1 Analogs of keratinocyte growth factor |
| 07/30/1997 | EP0785803A1 Use of a non-mammalian dna virus to express an exogenous gene in a mammalian cell |
| 07/30/1997 | EP0785716A1 Cytokine designated lerk-6 |
| 07/30/1997 | EP0682697A4 Method and apparatus for anchorage and suspension cell culture. |
| 07/30/1997 | EP0652976A4 Device and method for processing fat tissue to produce endothelial cell product. |
| 07/30/1997 | EP0505500B1 Endogenous gene expression modification with regulatory element by way of homologous recombination |
| 07/30/1997 | EP0481089B1 Human monoclonal antibody against glycoprotein gp iii of varicella zoster virus |
| 07/30/1997 | CN1155907A Transformation of guar |
| 07/30/1997 | CN1155582A Converted gene cell line for expressing surface antigen of hepatitis Beffectively |
| 07/29/1997 | US5652354 Stamen-selective promoters |
| 07/29/1997 | US5652352 Afamin: a human serum albumin-like gene |
| 07/29/1997 | US5652338 Neutrophil chemotactic factor |
| 07/29/1997 | US5652333 gC1q receptor, HIV-1 gp120 region binding thereto, and related peptides and targeting antibodies |
| 07/29/1997 | US5652224 Methods and compositions for gene therapy for the treatment of defects in lipoprotein metabolism |
| 07/29/1997 | US5652210 Soluble splice variant of the Fas (APO-1) antigen, FasΔTM |
| 07/29/1997 | US5652209 Administering transforming growth factor |
| 07/29/1997 | US5652138 Immunoreacts with human immunodeficiency virus glycoprotein |
| 07/29/1997 | US5652131 Cyclic GMP-binding, cyclic GMP-specific phosphodiesterase materials and methods |
| 07/29/1997 | US5652130 Retroviral vectors expressing tumor necrosis factor (TNF) |
| 07/29/1997 | US5652123 Protein having interleukin 13 activity, recombinant DNA coding for this protein, transformed cells and microorganisms |
| 07/29/1997 | US5652119 Recombinant feline herpesvirus vaccine |
| 07/29/1997 | US5652113 Contacting nonneuronal cells expressing on their cell surface the human serotonin receptor with chemical compound under conditions suitable for binding, detecting specific binding of compound to receptor |
| 07/29/1997 | US5652112 Assay for type I collagen carboxy-terminal telopeptide analytes |
| 07/29/1997 | US5652110 Antibodies to αvβ3 integrin |
| 07/29/1997 | US5652109 Antitumor agents; medical diagnosis |
| 07/29/1997 | US5652100 Stably transfected rodent fibroblast cell lines expressing human GABA-A -receptors |
| 07/29/1997 | US5651992 In vitro activation of human fetal cells |
| 07/29/1997 | US5651980 Methods of use of uncoated gel particles |
| 07/29/1997 | US5651979 Apparatus and method for delivering a biologically active compound into a biological environment |
| 07/29/1997 | US5651966 Wound healing agents |
| 07/29/1997 | CA1339102C Dna molecules useful in plant protection |
| 07/29/1997 | CA1339101C Production of guar alpha-galactosidase and immunologically related alpha-galactosidases by host organisms transformed with recombinant dna methods |
| 07/29/1997 | CA1339092C Method for the treatment of grafts prior to transplantation |
| 07/24/1997 | WO1997026523A2 Detection of a leptin receptor variant and methods for regulating obesity |
| 07/24/1997 | WO1997026370A1 Leptin receptor variants |
| 07/24/1997 | WO1997026366A1 Anthranilate synthase gene and use thereof |
| 07/24/1997 | WO1997026362A1 Nucleic acid molecules from plants coding enzymes which participate in the starch synthesis |
| 07/24/1997 | WO1997026360A1 Novel methods for the characterization of compounds which stimulate stf-1 expression in pancreatic islet cells |
| 07/24/1997 | WO1997026358A1 Compositions and methods for modulating cell proliferation using growth factor-polysaccharide binding fusion proteins |
| 07/24/1997 | WO1997026356A1 PHENYLALANYL-tRNA SYNTHETASE FROM STAPHYLOCOCCUS AUREUS |
| 07/24/1997 | WO1997026355A1 NOVEL VALYL-tRNA SYNTHETASE FROM STAPHYLOCOCCUS AUREUS |
| 07/24/1997 | WO1997026354A1 HISTIDYL-tRNA SYNTHETASE OF STAPHYLOCOCCUS AUREUS |
| 07/24/1997 | WO1997026351A1 STAPHYLOCOCCUS AUREUS TYROSYL-tRNA SYNTHETASE |
| 07/24/1997 | WO1997026349A1 LEUCYL tRNA SYNTHETASE OF STAPHYLOCOCCUS AUREUS |
| 07/24/1997 | WO1997026348A1 ASPARAGINYL tRNA SYNTHETASE OF STAPHYLOCOCCUS AUREUS |
| 07/24/1997 | WO1997026347A1 ARGINYL tRNA SYNTHETASE OF STAPHYLOCOCCUS AUREUS |
| 07/24/1997 | WO1997026346A1 NOVEL TRYPTOPHANYL-tRNA SYNTHETASE FROM STAPHYLOCOCCUS AUREUS |
| 07/24/1997 | WO1997026345A1 GLUTAMYL-tRNA SYNTHETASE FROM STAPHYLOCOCCUS AUREUS |
| 07/24/1997 | WO1997026344A1 ASPARTYL-tRNA SYNTHETASE OF STAPHYLOCOCCUS AUREUS |
| 07/24/1997 | WO1997026343A1 NOVEL PROLYL-tRNA SYNTHETASE FROM STAPHYLOCOCCUS AUREUS |
| 07/24/1997 | WO1997026342A1 THREONYL-tRNA SYNTHETASE OF STAPHYLOCOCCUS AUREUS |
| 07/24/1997 | WO1997026337A1 Methods for delivering dna to muscle cells using recombinant adeno-associated virus virions |
| 07/24/1997 | WO1997026336A1 Compositions for treating anemia |
| 07/24/1997 | WO1997026335A1 Db, the receptor for leptin, nucleic acids encoding the receptor, and uses thereof |
| 07/24/1997 | WO1997026333A1 Humanized green fluorescent protein genes and methods |
| 07/24/1997 | WO1997026331A2 Use of neuronal apoptosis inhibitor protein (naip) |
| 07/24/1997 | WO1997026329A1 Monoclonal antibody to herpes simplex virus and cell line producing same |
| 07/24/1997 | WO1997026328A1 Immunotherapy using cytotoxic t lymphocytes (ctl) |
| 07/24/1997 | WO1997026327A1 Compositions and methods for mediating cell cycle progression |